Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

Somatropin   save search

Health Canada Approves NGENLA (somatrogon) Injection for Pediatric Growth Hormone Deficiency
Published: 2021-10-29 (Crawled : 12:00) - biospace.com/
OPK | $1.255 3.72% 3.59% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 3.54% H: 2.76% C: -0.26%

growth hormone injection growth hormone
Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency
Published: 2021-09-24 (Crawled : 21:00) - globenewswire.com
PFE A | $25.42 -1.05% -0.04% 44M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
OPK | $1.255 3.72% 3.59% 4.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

fda growth hormone license growth hormone application
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Published: 2021-02-26 (Crawled : 14:00) - biospace.com/
PFE A | $25.42 -1.05% -0.04% 44M twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 0.18% C: -1.03%
OPK | $1.255 3.72% 3.59% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 4.82% H: 0.58% C: -2.87%

growth hormone growth hormone ema application
New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency
Published: 2021-01-28 (Crawled : 13:03) - globenewswire.com
OPK | $1.255 3.72% 3.59% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.08% H: 6.58% C: -4.27%

growth hormone drug growth hormone new drug application
US FDA Accepts Regulatory Submission from Pfizer and OPKO for Review of Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Published: 2021-01-04 (Crawled : 14:00) - biospace.com/
PFE A | $25.42 -1.05% -0.04% 44M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.19% C: -0.16%
OPK | $1.255 3.72% 3.59% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: 2.03% H: 7.19% C: 4.22%

growth fda submission growth hormone hormone fda acceptance
Gainers vs Losers
56% 44%

Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M twitter stocktwits trandingview |
Health Technology

SINT | $0.0365 59.39% 37.26% 470M twitter stocktwits trandingview |
Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M twitter stocktwits trandingview |
Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M twitter stocktwits trandingview |

GCTK | $0.715 36.27% 26.62% 640K twitter stocktwits trandingview |
Manufacturing

TCON | $2.33 36.26% 26.61% 2M twitter stocktwits trandingview |
Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M twitter stocktwits trandingview |

KZIA | $0.38 30.58% 23.42% 300K twitter stocktwits trandingview |
Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M twitter stocktwits trandingview |
Health Technology

ATNF | $1.91 29.05% 22.51% 310K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.